Analysis | Samples | Factors | Units |
---|---|---|---|
GC POSITIVE ION MODE | sgSLC1A5-1 IM 1 | Sample source:Human breast cancer cells | Genotype:ASCT2-KO | Treatment:50uM Serine | Abundance |
GC POSITIVE ION MODE | sgSLC1A5-1 IM 2 | Sample source:Human breast cancer cells | Genotype:ASCT2-KO | Treatment:50uM Serine | Abundance |
GC POSITIVE ION MODE | sgSLC1A5-1 IM 3 | Sample source:Human breast cancer cells | Genotype:ASCT2-KO | Treatment:50uM Serine | Abundance |
GC POSITIVE ION MODE | sgSLC1A5-3 IM 1 | Sample source:Human breast cancer cells | Genotype:ASCT2-KO | Treatment:50uM Serine | Abundance |
GC POSITIVE ION MODE | sgSLC1A5-3 IM 2 | Sample source:Human breast cancer cells | Genotype:ASCT2-KO | Treatment:50uM Serine | Abundance |
GC POSITIVE ION MODE | sgSLC1A5-3 IM 3 | Sample source:Human breast cancer cells | Genotype:ASCT2-KO | Treatment:50uM Serine | Abundance |
GC POSITIVE ION MODE | sgLuc IM 1 | Sample source:Human breast cancer cells | Genotype:Ctrl | Treatment:50uM Serine | Abundance |
GC POSITIVE ION MODE | sgLuc IM 2 | Sample source:Human breast cancer cells | Genotype:Ctrl | Treatment:50uM Serine | Abundance |
GC POSITIVE ION MODE | sgLuc IM 3 | Sample source:Human breast cancer cells | Genotype:Ctrl | Treatment:50uM Serine | Abundance |